Literature DB >> 11296578

Who should be screened for asymptomatic carotid artery stenosis? Experience from the Western New York Stroke Screening Program.

A I Qureshi1, V Janardhan, S E Bennett, A R Luft, L N Hopkins, L R Guterman.   

Abstract

OBJECTIVE: Identification of significant asymptomatic carotid artery stenosis (ACAS) is important because of the stroke-risk reduction observed with carotid endarterectomy. The authors developed and validated a simple scoring system based on routinely available information to identify persons at high risk for ACAS using data collected during a community health screening program at various sites in western New York. A total of 1331 unselected volunteers without previous stroke, transient ischemic attack, or carotid artery surgery were evaluated by personal interview and duplex ultrasound. The main outcome measure was carotid artery stenosis > 60% by duplex ultrasound. In the derivation set (n = 887), 4 variables were significantly associated with ACAS > 60%: age > 65 years (odds ratio [OR] = 4.1, 95% confidence interval [CI] = 2.6-6.7), current smoking (OR = 2.0, 95% CI = 1.2-3.5), coronary artery disease (OR = 2.4, 95% CI = 1.5-3.9), and hypercholesterolemia (OR = 1.9, 95% CI = 1.2-2.9). Three risk groups (low, intermediate, and high) were defined on the basis of total risk score assigned on the basis of the strength of association. The scheme effectively stratified the validation set (n = 444); the likelihood ratio and posttest probability for ACAS in the high-risk group were 3.0 and 35%, respectively, and in the intermediate and low-risk groups were 1.4 and 20% and 0.4 and 7%, respectively. Routinely available information can be used to identify persons in the community at high risk for ACAS. Doppler ultrasound screening in this subgroup may prove to be cost-effective and have an effect on stroke-free survival.

Entities:  

Mesh:

Year:  2001        PMID: 11296578     DOI: 10.1111/j.1552-6569.2001.tb00019.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  7 in total

Review 1.  Management of combined severe carotid and coronary artery disease.

Authors:  Marco Roffi; Flavio Ribichini; Fausto Castriota; Alberto Cremonesi
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

2.  Cilostazol prevents progression of asymptomatic carotid artery stenosis in patients with contralateral carotid artery stenting.

Authors:  T Kato; H Sakai; T Takagi; Y Nishimura
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-09       Impact factor: 3.825

3.  Evaluation of Carotid Ultrasonography Screening Among Kidney Transplant Candidates: A Single-Center, Retrospective Study.

Authors:  Chad W Rossitter; Ronald B Vigo; Ahmed Osama Gaber; Joshua T Swan; Wadi N Suki
Journal:  Transplant Direct       Date:  2017-02-09

4.  Validation of Risk Prediction Models to Detect Asymptomatic Carotid Stenosis.

Authors:  Michiel H F Poorthuis; Alison Halliday; M Sofia Massa; Paul Sherliker; Rachel Clack; Dylan R Morris; Robert Clarke; Gert J de Borst; Richard Bulbulia; Sarah Lewington
Journal:  J Am Heart Assoc       Date:  2020-04-20       Impact factor: 5.501

5.  Development and Internal Validation of a Risk Score to Detect Asymptomatic Carotid Stenosis.

Authors:  Michiel H F Poorthuis; Paul Sherliker; Dylan R Morris; M Sofia Massa; Robert Clarke; Natalie Staplin; Sarah Lewington; Gert J de Borst; Richard Bulbulia; Alison Halliday
Journal:  Eur J Vasc Endovasc Surg       Date:  2021-01-07       Impact factor: 7.069

6.  Carotid stenosis: what is the high-risk population?

Authors:  Jong Hun Park; Alvaro Razuk; Paulo Fernandes Saad; Gustavo José Politzer Telles; Walter Khegan Karakhanian; Alexandre Fioranelli; Alessandra Caivano Rodrigues; Giuliano Giova Volpiani; Pollyanna Campos; Roberto Massayoshi Yamada; Valter Castelli; Roberto Augusto Caffaro
Journal:  Clinics (Sao Paulo)       Date:  2012-08       Impact factor: 2.365

7.  Roadmap Consensus on Carotid Artery Plaque Imaging and Impact on Therapy Strategies and Guidelines: An International, Multispecialty, Expert Review and Position Statement.

Authors:  L Saba; W Brinjikji; J D Spence; M Wintermark; M Castillo; G J de Borst; Q Yang; C Yuan; A Buckler; M Edjlali; T Saam; D Saloner; B K Lal; D Capodanno; J Sun; N Balu; R Naylor; A V D Lugt; B A Wasserman; M E Kooi; J Wardlaw; J Gillard; G Lanzino; U Hedin; D Mikulis; A Gupta; J K DeMarco; C Hess; J V Goethem; T Hatsukami; P Rothwell; M M Brown; A R Moody
Journal:  AJNR Am J Neuroradiol       Date:  2021-07-29       Impact factor: 4.966

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.